Cover Image
Market Research Report
Product code 
1047091

Global Clinical Trial Management Market Forecast 2022-2030

Published: | Inkwood Research | 207 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global Clinical Trial Management Market Forecast 2022-2030
Published: January 19, 2022
Inkwood Research
Content info: 207 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

KEY FINDINGS

The global clinical trial management market is set to project a CAGR of 12.71% during the forecast period, 2022-2030. The growing number of clinical trials, research & development, rising chronic disease incidences, CTM software benefits, and research & development are significant growth drivers.

MARKET INSIGHTS

Clinical trial management systems include various components that comprise services, hardware, and software. It helps in maintaining the complex data obtained from clinical trials. Clinical trials are on the rise globally, attributed to technological advancements and the growing demand for advanced drugs with fewer side effects. The discovery of new treatments is propelled by rapid innovations in data management, biotechnology, and artificial intelligence. With every new drug, treatment, and device needing to undergo clinical trial, the volume of trials continues to rise.

Moreover, medicine is changing at a fast-paced pace. There is an increasing demand for services and software to manage the piling data from the rising clinical trials. Such factors are projected to drive market growth. However, the implantation costs, security concerns, and the lack of skilled healthcare professionals hinder the market growth.

REGIONAL INSIGHTS

The global clinical trial management market growth evaluation includes the analysis of Asia-Pacific, Europe, North America, and Rest of World. North America is estimated to harbor the largest revenue share. At the same time, Asia-Pacific is set to record the highest CAGR by 2028. The market prospects of Asia-Pacific are attributed to the increasing clinical trial management product awareness and dense population base.

COMPETITIVE INSIGHTS

The market has an increasing number of market players, along with a considerable scope of innovation. Bio-Optronics Inc, Medidata Solutions Inc, Arisglobal LLC, Bioclinica Inc, etc., are among the leading companies in the market.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Product Code: 24387

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. PARENT MARKET ANALYSIS - HEALTHCARE
  • 3.2. MARKET SCOPE
  • 3.3. KEY DRIVERS
    • 3.3.1. OUTSOURCING OF CLINICAL TRIALS
    • 3.3.2. GROWING NUMBER OF CLINICAL TRIALS
    • 3.3.3. AWARENESS REGARDING THE BENEFITS OF USING CTM SOFTWARE
    • 3.3.4. INCIDENCES OF CHRONIC DISEASES
    • 3.3.5. RESEARCH & DEVELOPMENT
  • 3.4. KEY RESTRAINTS
    • 3.4.1. SCARCITY OF SKILLED HEALTHCARE PROFESSIONALS
    • 3.4.2. COST OF IMPLEMENTATION
    • 3.4.3. SECURITY CONCERNS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON CLINICAL TRIAL MANAGEMENT MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY END-USER

  • 5.1. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
  • 5.2. CLINICAL RESEARCH ORGANIZATIONS
  • 5.3. HEALTHCARE PROVIDERS

6. MARKET BY PRODUCT TYPE

  • 6.1. ENTERPRISE-BASED CTM
  • 6.2. SITE-BASED CTM

7. MARKET BY DEPLOYMENT MODEL

  • 7.1. WEB-BASED DEPLOYMENT
  • 7.2. ON-PREMISE DEPLOYMENT
  • 7.3. CLOUD-BASED DEPLOYMENT

8. MARKET BY COMPONENT

  • 8.1. SOFTWARE
  • 8.2. HARDWARE
  • 8.3. SERVICES

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. KEY GROWTH ENABLERS
    • 9.1.3. KEY CHALLENGES
    • 9.1.4. KEY PLAYERS
    • 9.1.5. COUNTRY ANALYSIS
      • 9.1.5.1. UNITED STATES
      • 9.1.5.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. MARKET SIZE & ESTIMATES
    • 9.2.2. KEY GROWTH ENABLERS
    • 9.2.3. KEY CHALLENGES
    • 9.2.4. KEY PLAYERS
    • 9.2.5. COUNTRY ANALYSIS
      • 9.2.5.1. UNITED KINGDOM
      • 9.2.5.2. GERMANY
      • 9.2.5.3. FRANCE
      • 9.2.5.4. ITALY
      • 9.2.5.5. RUSSIA
      • 9.2.5.6. DENMARK
      • 9.2.5.7. HUNGARY
      • 9.2.5.8. SWEDEN
      • 9.2.5.9. SPAIN
      • 9.2.5.10. REST OF EUROPE
  • 9.3. ASIA-PACIFIC
    • 9.3.1. MARKET SIZE & ESTIMATES
    • 9.3.2. KEY GROWTH ENABLERS
    • 9.3.3. KEY CHALLENGES
    • 9.3.4. KEY PLAYERS
    • 9.3.5. COUNTRY ANALYSIS
      • 9.3.5.1. CHINA
      • 9.3.5.2. JAPAN
      • 9.3.5.3. INDIA
      • 9.3.5.4. SOUTH KOREA
      • 9.3.5.5. INDONESIA
      • 9.3.5.6. THAILAND
      • 9.3.5.7. VIETNAM
      • 9.3.5.8. AUSTRALIA & NEW ZEALAND
      • 9.3.5.9. REST OF ASIA-PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. MARKET SIZE & ESTIMATES
    • 9.4.2. KEY GROWTH ENABLERS
    • 9.4.3. KEY CHALLENGES
    • 9.4.4. KEY PLAYERS
    • 9.4.5. REGIONAL ANALYSIS
      • 9.4.5.1. LATIN AMERICA
      • 9.4.5.2. MIDDLE EAST AND AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. MERGERS & ACQUISITIONS
    • 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 10.1.3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
  • 10.2. COMPANY PROFILES
    • 10.2.1. ADVARRA (FORTE RESEARCH SYSTEMS INC)
    • 10.2.2. ARISGLOBAL LLC
    • 10.2.3. BIOCLINICA INC
    • 10.2.4. BIO-OPTRONICS INC
    • 10.2.5. IBM CORPORATION
    • 10.2.6. MEDIDATA SOLUTIONS INC
    • 10.2.7. MEDNET SOLUTIONS INC
    • 10.2.8. ORACLE CORPORATION
    • 10.2.9. PAREXEL INTERNATIONAL CORPORATION
    • 10.2.10. VEEVA SYSTEMS INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - CLINICAL TRIAL MANAGEMENT
  • TABLE 2: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 3: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 4: GLOBAL PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 5: GLOBAL PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 6: GLOBAL CLINICAL RESEARCH ORGANIZATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 7: GLOBAL CLINICAL RESEARCH ORGANIZATIONS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 8: GLOBAL HEALTHCARE PROVIDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 9: GLOBAL HEALTHCARE PROVIDERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 10: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 11: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 12: GLOBAL ENTERPRISE-BASED CTM MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 13: GLOBAL ENTERPRISE-BASED CTM MARKET, BY REGION, FORECAST YEARS 2022-2030 (IN $ MILLION)
  • TABLE 14: GLOBAL SITE-BASED CTM MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 15: GLOBAL SITE-BASED CTM MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 16: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 17: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 18: GLOBAL WEB-BASED DEPLOYMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 19: GLOBAL WEB-BASED DEPLOYMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 20: GLOBAL ON-PREMISE DEPLOYMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 21: GLOBAL ON-PREMISE DEPLOYMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 22: GLOBAL CLOUD-BASED DEPLOYMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 23: GLOBAL CLOUD-BASED DEPLOYMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 24: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 25: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 26: GLOBAL SOFTWARE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 27: GLOBAL SOFTWARE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 28: GLOBAL HARDWARE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 29: GLOBAL HARDWARE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 30: GLOBAL SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 31: GLOBAL SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 32: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 33: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 34: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 35: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 36: KEY PLAYERS OPERATING IN NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET
  • TABLE 37: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 38: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 39: KEY PLAYERS OPERATING IN EUROPE CLINICAL TRIAL MANAGEMENT MARKET
  • TABLE 40: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 41: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 42: KEY PLAYERS OPERATING IN ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET
  • TABLE 43: REST OF WORLD CLINICAL TRIAL MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 44: REST OF WORLD CLINICAL TRIAL MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 45: KEY PLAYERS OPERATING IN THE REST OF WORLD CLINICAL TRIAL MANAGEMENT MARKET
  • TABLE 46: LIST OF MERGERS & ACQUISITIONS
  • TABLE 47: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 48: LIST OF PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
  • FIGURE 6: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)
  • FIGURE 7: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY CLINICAL RESEARCH ORGANIZATIONS, 2022-2030 (IN $ MILLION)
  • FIGURE 8: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY HEALTHCARE PROVIDERS, 2022-2030 (IN $ MILLION)
  • FIGURE 9: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021
  • FIGURE 10: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY ENTERPRISE-BASED CTM, 2022-2030 (IN $ MILLION)
  • FIGURE 11: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY SITE-BASED CTM, 2022-2030 (IN $ MILLION)
  • FIGURE 12: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY DEPLOYMENT MODEL, IN 2021
  • FIGURE 13: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY WEB-BASED DEPLOYMENT, 2022-2030 (IN $ MILLION)
  • FIGURE 14: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY ON-PREMISE DEPLOYMENT, 2022-2030 (IN $ MILLION)
  • FIGURE 15: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY CLOUD-BASED DEPLOYMENT, 2022-2030 (IN $ MILLION)
  • FIGURE 16: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2021
  • FIGURE 17: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY SOFTWARE, 2022-2030 (IN $ MILLION)
  • FIGURE 18: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY HARDWARE, 2022-2030 (IN $ MILLION)
  • FIGURE 19: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY SERVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 20: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 21: UNITED STATES CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 22: CANADA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 23: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 24: UNITED KINGDOM CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 25: GERMANY CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 26: FRANCE CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 27: ITALY CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 28: RUSSIA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 29: DENMARK CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 30: HUNGARY CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 31: SWEDEN CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 32: SPAIN CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 33: REST OF EUROPE CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 34: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 35: CHINA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 36: JAPAN CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 37: INDIA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 38: SOUTH KOREA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 39: INDONESIA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 40: THAILAND CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 41: VIETNAM CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 42: AUSTRALIA & NEW ZEALAND CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 43: REST OF ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 44: REST OF WORLD CLINICAL TRIAL MANAGEMENT MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 45: LATIN AMERICA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 46: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)